Biopharma Business

Tag "Allergan"

Allergan and Novartis Collaborate on Multi-Therapy Treatment for NASH

Allergan, a global biopharmaceutical company, announced that it has entered into a clinical trial agreement with Novartis to conduct a Phase 2b study, using Allergan’s cenicriviroc (CVC) and Novartis’ lead FXR

Read Full Article

Data Supports Advancement of Botox as Depression Treatment

Allergan plc, a global pharmaceutical company announced topline data from a phase II study with major depressive disorder (MDD). The study evaluated the efficacy, safety and tolerability of a single administration

Read Full Article

Pharma company Allergan to invest €42m in Irish operations

Dublin-headquartered pharma company Allergan is to invest €42 million in its Irish operations this year. The company, which employs approximately 1,700 people in the Republic, has also announced details of

Read Full Article

Dublin-headquartered Allergan to buy Zeltiq Aesthetics for $2.48bn

Botox maker Allergan said it would buy body-contouring product maker Zeltiq Aesthetics for about $2.48 billion (€2.34 billion), adding muscle to its line-up of products used to fight fat and

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here